These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218 [TBL] [Abstract][Full Text] [Related]
4. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979 [TBL] [Abstract][Full Text] [Related]
5. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures. Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. Ashworth J; Kahan MC; Breathnach SM J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952 [TBL] [Abstract][Full Text] [Related]
7. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin. Cruchley AT; Speight PM; Williams DM Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627 [TBL] [Abstract][Full Text] [Related]
8. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study. Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303 [TBL] [Abstract][Full Text] [Related]
9. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells. Morhenn VB; Benike CJ; Charron DJ; Cox A; Mahrle G; Wood GS; Engleman EG J Invest Dermatol; 1982 Nov; 79(5):277-82. PubMed ID: 6752290 [TBL] [Abstract][Full Text] [Related]
10. HLA-DR+/T6- Langerhans cells of the human cornea. Seto SK; Gillette TE; Chandler JW Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1719-22. PubMed ID: 3498703 [TBL] [Abstract][Full Text] [Related]
11. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069 [TBL] [Abstract][Full Text] [Related]
12. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation. Cooper KD; Neises GR; Katz SI J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821 [TBL] [Abstract][Full Text] [Related]
13. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells. Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 surface antigens of human epidermal Langerhans cells. De Panfilis G; Manara GC; Ferrari C; Torresani C J Invest Dermatol; 1988 Dec; 91(6):547-52. PubMed ID: 3263998 [TBL] [Abstract][Full Text] [Related]
15. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Czernielewski JM; Schmitt D; Faure MR; Thivolet J Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266 [TBL] [Abstract][Full Text] [Related]
16. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells. Claudy AL; Rouchouse B Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893 [TBL] [Abstract][Full Text] [Related]
17. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours. Löning T; Caselitz J; Seifert G; Weber K; Osborn M Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705 [TBL] [Abstract][Full Text] [Related]
18. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. Haftek M; Faure M; Schmitt D; Thivolet J J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681 [TBL] [Abstract][Full Text] [Related]
19. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. Meunier L; Bohjanen K; Voorhees JJ; Cooper KD J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]